Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver disease

Published:2021-07-06 Issue: Volume: Page:
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Hagström Hannes¹²³^ORCID,Kechagias Stergios⁴,Ekstedt Mattias⁴

Affiliation:

1. Division of Hepatology Department of Upper GI diseases Karolinska University Hospital Stockholm Sweden

2. Clinical Epidemiology Division Department of Medicine Karolinska Institutet Solna Stockholm Sweden

3. Department of Medicine Karolinska Institutet Huddinge Stockholm Sweden

4. Division of Diagnostics and Specialist Medicine Department of Health, Medicine and Caring Sciences Linköping University Linköping Sweden

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13343

Reference116 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

3. External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

4. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

5. Long-term follow-up of patients with NAFLD and elevated liver enzymes

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

2. RNF31 alleviates liver steatosis by promoting p53/BNIP3-related mitophagy in hepatocytes;Free Radical Biology and Medicine;2024-07

3. Temporal relationship between hepatic steatosis and blood pressure elevation and the mediation effect in the development of cardiovascular disease;Hypertension Research;2024-05-17

4. Aspirin and NSAIDs are associated with reduced cancer and mortality risk in patients with chronic liver diseases – a Swedish cohort study;2024-03-11

5. Endpoints in NASH Clinical Trials: Are We Blind in One Eye?;Metabolites;2024-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3